Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02325947
Other study ID # iMove
Secondary ID
Status Completed
Phase N/A
First received December 8, 2014
Last updated September 27, 2017
Start date January 2015
Est. completion date September 2017

Study information

Verified date September 2017
Source Russian Academy of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the efficacy of non-invasive BCI-exoskeleton technology based on EEG patterns recognition matching to motor imagery in post-stroke patients with hand paresis.


Description:

The BCI training is based on EEG activity patterns recording during hand motor imagery. A subject sit comfortably 1m from a computer screen which presents visual instructions during the session. The robotic exoskeleton is fixed to the paretic hand. Subject visually fixate on a circle presented in the center of the screen and receive instructions from three surrounding rhomboidal arrows. Subject is given three commands instructing them to relax or imagine slow hand opening movement with the right or left hand. The "Relax" command means that the subject have to sit still and look at the center of the screen. Commands are presented randomly, each of 10 sec duration.

A visual cue provides the subject with feedback regarding the mental task recognition: the central circle turned green if the classifier recognizes the task in agreement with the given command, or remains white if the signal is not recognized. In addition to visual feedback the subject is provided with kinesthetic feedback: the exoskeleton is opening the hand when the classifier recognizes the imagery of paretic hand movement.

The EEG is registered with 30 electrodes distributed over the head in accordance with the standard international 10-20 system. EEG signals are filtered from 5-30Hz. A Bayesian approach for EEG pattern classifying is used in the system. The activity sources most relevant for BCI functioning will be identified using an independent component analysis (ICA). Classification accuracy will by measured with Cohen's kappa (Kohavi and Provost, 1998). The procedure may consist from up to three sessions, the duration of 1 session is 10 min, there are 5 min time brake between session and total duration of procedure is up to 45 min. The number of procedures - at least 10. The maximal interval between procedures is 3 days.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date September 2017
Est. primary completion date September 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Signed informed consent

- Medical history of primary acute cerebrovascular event (ischemic or hemorrhagic stroke) at least 4 weeks before screening

- focal stroke located in a hemisphere

- post stroke hand paresis (mild to plegia according to Medical Research Council (MRC) Scale for Muscle Strength)

Exclusion Criteria:

- Montreal Cognitive Assessment (MoCA) scale < 22

- Left handedness

- Sensory aphasia

- Severe impairment of vision

- Modified Ashworth Scale (MAS) = 4

Study Design


Related Conditions & MeSH terms


Intervention

Device:
hand exoskeleton, brain-computer interface (BCI),
Hand exoskeleton, brain-computer interface (BCI) 10 sessions of 45-minutes
hand exoskeleton, sham BCI
Hand exoskeleton, sham BCI 10 sessions of 45-minutes (BCI imitation)

Locations

Country Name City State
Russian Federation Research Center of Neurology of RAMS Moscow

Sponsors (2)

Lead Sponsor Collaborator
Russian Academy of Medical Sciences Pirogov Russian National Research Medical University

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Baseline in hand paresis level and hand muscle spasticity ARAT; Fugl-Meyer, Modified Ashworth scale Week 2
Secondary Long-term changes from Baseline in hand paresis level and hand muscle spasticity ARAT; Fugl-Meyer, Modified Ashworth scale week 4, week 12, week 24
See also
  Status Clinical Trial Phase
Recruiting NCT01466296 - The Middle East "Stepping Forward" Project (MESF) Phase 2